buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 recall — FDA D-0445-2017
Failed Dissolution Specifications; 18 month stability time point
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Failed Dissolution Specifications; 18 month stability time point
Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.
If a reader selects Multi-study review prior to the original study completing its loading process and then immediately returns to image review of the original study, it is possible that not…
When the UF Rate, Goal or Time is adjusted using the up and down arrow keys, and the change is cancelled by using the esc key, the cancelled UF Rate is actually being executed…
Products were labeled with incorrect Global Trade Item Numbers. The GTIN on the label identifies the devices as another.
Incorrect dose after editing beam number an wedge angle.
Complaints of sheath separation, kinking, and/or tip damage during use.
Ultradent Products, Inc. announces a voluntary field action for the NanoTips 30g 20pk, 100pk because the cannula attached to the tip hub may become loose or detach from the blue base that…
A change in the calibration curve causing an increase in false prozone flags.
Endologix updated information on the rates of Type III endoleaks and suggestions for patient surveillance and treatment.
Lack of 510k clearance for design modification.
During an infusion, a false Air-in-Line (AIL) alarm would cause the infusion to be interrupted.
Internal testing has demonstrated that the indicated kit lots produce false positive results when tested with some broth specimens.
Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System (AFX System).
Complaints of sheath separation, kinking, and/or tip damage during use.
Complaints of sheath separation, kinking, and/or tip damage during use.
Product complaints indicated that the part and lot numbers on the packaging differed from the physical product inside the packaging. Risk of delay in surgery.
Beckman Coulter initiated a design change to update the Automate PC image to accommodate the operating system change to Windows 10.
A drift of the performance with the BK test (BK virus, worst case application) was observed for some silica batches of Magnetic Silica (MagSil). This is the same issue as in recall…
Endologix initiated a correction by updating reports for the cumulative clinical data and information on the Powerlink System and the AFX Endovascular AAA System (AFX System).
Products were labeled with incorrect Global Trade Item Numbers. The GTIN on the label identifies the devices as another.
Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular AAA System (AFX System).
When the UF Rate, Goal or Time is adjusted using the up and down arrow keys, and the change is cancelled by using the esc key, the cancelled UF Rate is actually being executed…
Browse recent months with enough recall history for useful comparison.